Screener
BioMarin Pharmaceuticals BMRN Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
FAQ
- What is BioMarin Pharmaceuticals's price / sales?
- BioMarin Pharmaceuticals (BMRN) reported price / sales of 3.2× in Q2 2026.
- How has BioMarin Pharmaceuticals's price / sales changed year-over-year?
- BioMarin Pharmaceuticals's price / sales decreased by 5.2% year-over-year, from 3.4× to 3.2×.
- What is the long-term trend for BioMarin Pharmaceuticals's price / sales?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's price / sales has grown at a -16.3% compound annual growth rate (CAGR), from 8.7× to 3.5×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about BioMarin Pharmaceuticals's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude